| Toward a Unified Hypothesis of Parkinson's Pathogenesis |
Timothy Greenamyre, MD, PhD
Pittsburgh Institute for Neurodegenerative Diseases Director |
| Debate 1: Premotor PD can be diagnosed |
Pro: Matthew Stern, MD
Philadelphia PADRECC Co- Director
Con: Webster Ross, MD
Honolulu Consortium Center Director
|
| Debate 2: Initiation of therapy should be delayed until symptoms become disabling or bothersome |
Pro: Eugene Lai, MD
Houston PADRECC Director
Con: John Duda, MD (1)
Philadelphia PADRECC Director
|
| Debate 3: Continuous dopaminergic stimulation minimizes levodopa-induced motor complications |
Pro: Jeff Bronstein, MD, PhD
Southwest PADRECC Director
Con: Ergun Uc, MD
Iowa City Consortium Center Director
|
| Debate 4: DBS utilization will expand in the treatment of PD in the future |
Pro: William Marks, MD
San Francisco PADRECC Director
Con: Fredy Revilla, MD
Cincinnati Consortium Center Director
|
| Debate 5: Dementia in PD is due to diffuse Lewy body disease |
Pro: Jim Leverenz, MD
Northwest PADRECC
Con: John Duda, MD(2)
Philadelphia PADRECC Director
|
| Approaches to Managing Neuropsychiatric Complications |
Daniel Weintraub, MD
Philadelphia PADRECC |
| Approaches to DBS Programming |
William Marks, MD
San Francisco PADRECC
Susan Heath, RN, MS
San Francisco PADRECC
*Supplemental article for review* |
| Information from the HSR&D PADRECC Evaluation |
Marty Charns, DBA
Irene Cramer, PhD, MSSA, LICSW
VA Center for Organization, Leadership and Management Research
|
